Deal Highlights for Jan 2016:
- Strides Shasun received CCI approval to acquire 7 brands from Johnson and Johnson
- Jubilant Biosys collaborates with Sanofi to develop metabolic disorders therapy
- BioQ Pharma and Cipla enter into an agreement to commercialize BioQ's Ropivacaine Infusion System in India
- Medicines Patent Pool (MPP) announced its first round of sub-licenses for the generic production of Bristol-Myers Squibb's daclatasvir, with Cipla, Emcure, Hetero and Natco
- Cipla completed stake sale in Biomab Holding for USD 2.5 million
- Drug companies like Torrent, Dr Reddy's, Aurobindo, Cipla and Lupin are in initial discussions to bid for Sagent Pharmaceuticals
For more such news and updates, please join our Group "Global Life Science Business in India" on LinkedIn.
Aagami Updates:
- Aagami 2015 Roundup -
- 5 deals for its various clients
- Several consulting and market intelligence assignments
- Attended several conference and trade shows in US, EU and other parts of the world
- Fortification of Aagami team with a partner level resource with global experience and expertise in Latin America and US
- Jan 2016 - Participated in JP Morgan Healthcare and Biotech Showcase 2016 in San Francisco with over 40 one on one business meetings.
- Feb 2016 - Aagami to participate in Bio Asia 2016 in Hyderabad, India.